Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's EV-to-FCF or its related term are showing as below:
ISX:SAME'
s EV-to-FCF Range Over the Past 10 Years
Min: -908.76 Med: -28.61 Max: 304.28
Current: 142.39
During the past 13 years, the highest EV-to-FCF of PTrana Meditama Metropolitan Tbk was 304.28. The lowest was -908.76. And the median was -28.61.
ISX:SAME's EV-to-FCF is ranked worse than 93.35% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.99
vs ISX:SAME: 142.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PTrana Meditama Metropolitan Tbk's PE Ratio (TTM) for today is calculated as:
PTrana Meditama Metropolitan Tbk's share price for today is Rp306.00.
PTrana Meditama Metropolitan Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1.135.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PTrana Meditama Metropolitan Tbk EV-to-FCF Related Terms
PTrana Meditama Metropolitan Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's EV-to-FCF falls into.
PTrana Meditama Metropolitan Tbk's current Enterprise Value is Rp6,449,650 Mil.
PTrana Meditama Metropolitan Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp44,573 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a EV-to-FCF of 144.70 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #379 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 93.3%.
Is PTrana Meditama Metropolitan Tbk's EV-to-FCF too high?
PTrana Meditama Metropolitan Tbk's current EV-to-FCF is 144.70. The Healthcare Providers & Services industry median EV-to-FCF is 17.99. PTrana Meditama Metropolitan Tbk's value of 144.70 is 704.3% above this industry median. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #379 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #379 out of 406 companies for EV-to-FCF. This places PTrana Meditama Metropolitan Tbk in the lower half of its industry. The industry median EV-to-FCF is 17.99. PTrana Meditama Metropolitan Tbk's value of 144.70 is 704.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.99, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current EV-to-FCF of 144.70 is 704.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current EV-to-FCF is 144.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current EV-to-FCF is 144.70 and 704.3% above the Healthcare Providers & Services industry median of 17.99. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current EV-to-FCF is 144.70 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
EV-to-FCF: 144.70
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 704.3% above the Healthcare Providers & Services median (#379 of 406)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
